NCT00967200CompletedNot Applicable
Identification of Genes Involved in the Pathogenesis of Gliomas by Transcriptome Analysis
University Hospital, Montpellier2 sites in 1 country180 target enrollmentStarted: November 2003Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 180
- Locations
- 2
- Primary Endpoint
- Pathophysiology of gliomas
Study Overview
Brief Summary
RATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
PURPOSE: This research study is looking at tissue samples from patients with glioma or other brain tumors.
Detailed Description
OBJECTIVES:
Primary
- To better understand the pathophysiology of gliomas and identify molecular markers that may predict prognosis and progression or that could identify new therapeutic approaches.
Secondary
- To compare gene expression profiles, in terms of response to treatment, and attempt to isolate subgroups of patients with objective response to certain types of chemotherapy or radiotherapy.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to 120 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Pathophysiology of gliomas
Time Frame: 1 day
Pathophysiology of gliomas that may predict prognosis and progression or that could identify new therapeutic
Secondary Outcomes
- Identification of molecular(1 day)
Investigators
Study Sites (2)
Loading locations...
Similar Trials
Completed
Not Applicable
Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid LeukemiaLeukemiaNCT00897182Alliance for Clinical Trials in Oncology96
Unknown
Not Applicable
Study of Biomarkers in Blood and/or Tumor Tissue Samples From Patients With Ductal Carcinoma in Situ and From Healthy VolunteersBreast CancerNCT00935233Queen Mary University of London6,000
Completed
Not Applicable
Gene Expression Profiles in Patients With Metastatic Pancreatic CancerPancreatic CancerNCT00897741Barbara Ann Karmanos Cancer Institute10
Terminated
Not Applicable
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant MelanomaMelanoma (Skin)NCT00991991Case Comprehensive Cancer Center5
Completed
Not Applicable
S9704-S0014-S0313A Studying Genes in Samples From Patients With Limited or Advanced Diffuse Large B-Cell LymphomaLymphomaNCT01563861SWOG Cancer Research Network397
